Diabetes researchers are reporting early success in a first-in-humans clinical trial to test whether pancreatic cells grown from stem cells can be safely implanted and begin to produce insulin. The team reported on their proof of concept and safety study in a newly published paper in the journal Cell Reports Medicine. Of 17 patients who received implants, 35 percent...